Follow our Pages for the latest updates

Lateral Flow Immunoassay (LFIA) and Rapid Diagnostics

Conventional laboratory-based analytical methods, such as high-performance liquid chromatography (HPLC), gas chromatography (GC), mass spectrometry (MS), enzyme-linked immunosorbent assay (ELISA), and real-time polymerase chain reaction (qPCR), require complex and lengthy procedures to obtain a result. However, several situations often require fast and on-site analyte detection, which is where LFIA excels.

The Lateral Flow Immunoassay (LFIA) is a highly effective analytical platform that allows for on-site detection of target substances. It has revolutionized the way we approach sample testing, shifting from a lab-to-sample model to a sample-to-lab model, which has vastly improved decision-making and turnaround time.

The LFIA's unique features have made it an attractive tool for clinical diagnostics, where it has enabled more prompt diagnosis and treatment decisions. Its rapidity, simplicity, and relative cost-effectiveness, as well as the ability to be used by nonskilled personnel, have contributed to its wide acceptance. This acceptance has led to the LFIA's application in fields beyond clinical diagnostics, such as food and feed safety, veterinary medicine, environmental control, and others.

The LFIA's attractive features have driven its widespread acceptance and appeal, making it a valuable tool for a range of applications.

COVERING A WIDE RANGE OF INFECTIOUS DISEASES